Status:
RECRUITING
VertiGreens Investigating the Effects of Iron Biofortification of Microgreens on Iron Status in Women
Lead Sponsor:
University of Aberdeen
Conditions:
Iron Biomarkers/Status
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The investigators present a diet intervention study, to be conducted as a within-subject design, to assess the effect of the provision of iron biofortified microgreens on iron intake and status in wom...
Detailed Description
In this study microgreens that were grown using agronomic iron biofortification will be supplied to women to add to their diet to establish the potential nutritional impact of iron biofortified microg...
Eligibility Criteria
Inclusion
- Healthy females
- 15 of reproductive age (18-49)
- 15 postmenopausal (not had their period for an entire year)
Exclusion
- Medication exclusion criteria:
- Supplementing iron or vitamin B12
- Smoking or vaping
- Taking anticoagulant medication (blood thinners) except for Aspirin 75mg
- Medical exclusion criteria:
- Anyone who is planning to be pregnant, is pregnant or breastfeeding
- Anyone with iron or vitamin B12 deficiency anaemia
- Anyone with history of anaemia in the past 3 months that required treatment
- Anyone who has Hb \<120 g/L (12 g/dL) at screening
- Anyone with food allergies, self-reported food sensitivity or intolerance
- Anyone with coeliac disease or gluten intolerance
- Anyone suffering from a psychiatric disorder or any type of substance abuse
- Anyone with Type 1 diabetes and Type 2 diabetes
- Anyone suffering from unregulated thyroid disease
- Anyone with gastrointestinal conditions or bariatric surgery
- Anyone with haematological conditions including Thrombocytopaenia and Sickle cell anaemia
- Other exclusion criteria:
- Anyone with unsuitable veins for blood sampling
- Anyone who donated blood in the last 16 weeks
- Anyone who is unable to fluently speak, read and understand English
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06972927
Start Date
May 1 2025
End Date
December 1 2025
Last Update
June 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rowett Institute, University of Aberdeen
Aberdeen, United Kingdom, AB25 2ZD